Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III)
Takanari Kitazono(Kyushu University), Kazumi Kimura(Nippon Medical School), Nobuyuki Koyama(Daiichi Sankyo (Germany)), Masahiro Kamouchi(Kyushu University), Masato Nakamura(Toho University), Kazuo Umemura(Tokyo University of Science), Junko Tsutsumi(Daiichi Sankyo (Germany)), Hajime Matsuo(Daiichi Sankyo (Germany)), Yuji Matsumaru(University of Tsukuba)
Cited by 26
Related Papers
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease
|Circulation Journal|2020|353
Secular Trends in Cardiovascular Disease and Its Risk Factors in Japanese
|Circulation|2013|287
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
|The Lancet Neurology|2019|216
Postischemic Gene Transfer of Interleukin-10 Protects Against Both Focal and Global Brain Ischemia
|Circulation|2005|201
Proteinuria and clinical outcomes after ischemic stroke
|Neurology|2012|198